Mothers against decapentaplegic homolog 8 (SMAD8) (SMAD8)

Mothers against decapentaplegic homolog 8 (SMAD8), also known as Smad8, is a receptor-regulated SMAD (R-SMAD) protein that serves as a key intracellular mediator in the transforming growth factor β (TGF-β) superfamily signaling pathways, particularly downstream of bone morphogenetic protein (BMP) receptors like ALK-2. Upon phosphorylation by activated type I serine/threonine kinase receptors such as ALK-2, SMAD8 forms heteromeric complexes with the common mediator SMAD4 (Co-SMAD), translocates to the nucleus, and regulates transcription of target genes involved in mesoderm patterning, cell differentiation, and development. It shares structural features with other R-SMADs, including conserved MH1 (DNA-binding) and MH2 (transcriptional activation) domains, a variable linker region, and a C-terminal SSXS phosphorylation motif. SMAD8 functions similarly to SMAD1 and SMAD5 in transducing BMP signals, activating genes like Xbra and Xnot in Xenopus embryos and influencing processes such as notochord formation and central nervous system development in mammals. Dysregulation of SMAD8-mediated BMP signaling has been implicated in developmental disorders and cancer, though it is not a primary direct drug target, with related SMAD family members showing antagonistic roles in TGF-β pathways.

Other names

Smad8MADH6